{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T17:12:31Z","timestamp":1790183551526,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000764","name":"King&apos;s College London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000764","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015615","name":"National Drug Abuse Treatment Clinical Trials Network","doi-asserted-by":"publisher","award":["5UG1DA013714"],"award-info":[{"award-number":["5UG1DA013714"]}],"id":[{"id":"10.13039\/100015615","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015615","name":"National Drug Abuse Treatment Clinical Trials Network","doi-asserted-by":"publisher","award":["CTN-0148"],"award-info":[{"award-number":["CTN-0148"]}],"id":[{"id":"10.13039\/100015615","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.drugalcdep.2025.112993","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T16:03:24Z","timestamp":1764345804000},"page":"112993","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Quality of life and treatment effectiveness direct and indirect effects on cocaine abstinence outcomes during cocaine use disorder treatment"],"prefix":"10.1016","volume":"278","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5095-2822","authenticated-orcid":false,"given":"Crystal L.","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2551-4772","authenticated-orcid":false,"given":"Sterling M.","family":"McPherson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9522-3677","authenticated-orcid":false,"given":"Nicole","family":"Rodin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8814-542X","authenticated-orcid":false,"given":"Sean E.","family":"Hovland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Akana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre QC","family":"Miguel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Marsden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3880-2589","authenticated-orcid":false,"given":"Andrew J.","family":"Saxon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.drugalcdep.2025.112993_bib1","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1177\/0022042613491100","article-title":"Patterns and correlates of adult American Indian substance use","volume":"43","author":"Akins","year":"2013","journal-title":"J. Drug Issues"},{"issue":"4","key":"10.1016\/j.drugalcdep.2025.112993_bib2","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1037\/pha0000034","article-title":"Sex effects in cocaine-using methadone patients randomized to contingency management interventions","volume":"23","author":"Burch","year":"2015","journal-title":"Exp. Clin. Psychopharm."},{"key":"10.1016\/j.drugalcdep.2025.112993_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.drugalcdep.2014.01.012","article-title":"Toward empirical identification of a clinically meaningful indicator of treatment outcome: features of candidate indicators and evaluation of sensitivity to treatment effects and relationship to one year follow up cocaine use outcomes","volume":"137","author":"Carroll","year":"2014","journal-title":"Drug Alcohol Depen"},{"key":"10.1016\/j.drugalcdep.2025.112993_bib4","article-title":"Clinical issues in intensive outpatient treatment","author":"Center for Substance Abuse Treatment","year":"2006","journal-title":"Rockv. (MD) Treat. Improv. Protoc. (TIP) Ser. No. 47"},{"key":"10.1016\/j.drugalcdep.2025.112993_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12955-014-0148-6","article-title":"Psychometric evaluation, using Rasch analysis, of the WHOQOL-BREF in heroin-dependent people undergoing methadone maintenance treatment: further item validation","volume":"12","author":"Chang","year":"2014","journal-title":"Health Qual. Life Outcomes"},{"issue":"1","key":"10.1016\/j.drugalcdep.2025.112993_bib6","first-page":"196","article-title":"Quality of life in patients with alcohol use disorders admitted to de-addiction centers using WHOQOL-BREF scale\u2014a cross-sectional study","volume":"12","author":"Colaco","year":"2023","journal-title":"J. Educ. Health Promot."},{"key":"10.1016\/j.drugalcdep.2025.112993_bib7","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.drugalcdep.2014.10.007","article-title":"Gender differences in clinical outcomes for cocaine dependence: randomized clinical trials of behavioral therapy and disulfiram","volume":"145","author":"DeVito","year":"2014","journal-title":"Drug Alcohol Depen"},{"issue":"3","key":"10.1016\/j.drugalcdep.2025.112993_bib8","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.ygyno.2014.04.002","article-title":"Preoperative quality of life and surgical outcomes in gynecologic oncology patients: a new predictor of operative risk?","volume":"133","author":"Doll","year":"2014","journal-title":"Gynecol. Oncol."},{"issue":"16","key":"10.1016\/j.drugalcdep.2025.112993_bib9","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1002\/cncr.31556","article-title":"Quality of life as a prognostic indicator of survival: a pooled analysis of individual patient data from Canadian cancer trials group clinical trials","volume":"124","author":"Ediebah","year":"2018","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.drugalcdep.2025.112993_bib10","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jsat.2014.05.006","article-title":"The relationship between recovery and health-related quality of life","volume":"47","author":"Garner","year":"2014","journal-title":"J. Subst. Abus. Treat."},{"issue":"14","key":"10.1016\/j.drugalcdep.2025.112993_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph18147442","article-title":"In-treatment changes in quality of life-related variables in therapeutic communities for cocaine abusers: are these changes associated with clinical outcomes?","volume":"18","author":"Gonz\u00e1lez-Saiz","year":"2021","journal-title":"Int J. Environ. Res Public Health"},{"issue":"1","key":"10.1016\/j.drugalcdep.2025.112993_bib12","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/15504263.2014.975004","article-title":"Dual recovery among people with serious mental illnesses and substance problems: a qualitative analysis","volume":"11","author":"Green","year":"2015","journal-title":"J. Dual Diagn."},{"issue":"2-3","key":"10.1016\/j.drugalcdep.2025.112993_bib13","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1080\/14659890412331336444","article-title":"Gender differences in problems and needs among chronic, high-risk crack abusers: results of a randomized controlled trial","volume":"10","author":"Henskens","year":"2005","journal-title":"J. Subst. Use"},{"issue":"4","key":"10.1016\/j.drugalcdep.2025.112993_bib14","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jsat.2012.06.001","article-title":"Effect of quality chronic disease management for alcohol and drug dependence on addiction outcomes","volume":"43","author":"Kim","year":"2012","journal-title":"J. Subst. Abus. Treat."},{"issue":"1","key":"10.1016\/j.drugalcdep.2025.112993_bib15","first-page":"44","article-title":"The case for considering quality of life in addiction research and clinical practice","volume":"6","author":"Laudet","year":"2011","journal-title":"Addict. Sci. Clin. Pr."},{"key":"10.1016\/j.drugalcdep.2025.112993_bib16","unstructured":"Ling, W., 2012. Cocaine Use Reduction with Buprenorphine (CURB)."},{"key":"10.1016\/j.drugalcdep.2025.112993_bib17","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2147\/SAR.S38902","article-title":"The treatment effectiveness assessment (TEA): an efficient, patient-centered instrument for evaluating progress in recovery from addiction","author":"Ling","year":"2012","journal-title":"Subst. Abus. Rehabil. 3(1"},{"issue":"8","key":"10.1016\/j.drugalcdep.2025.112993_bib18","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1111\/add.13375","article-title":"Buprenorphine+ naloxone plus naltrexone for the treatment of cocaine dependence: the Cocaine Use Reduction with Buprenorphine (CURB) study","volume":"111","author":"Ling","year":"2016","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2025.112993_bib19","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2147\/SAR.S198361","article-title":"Measuring recovery in opioid use disorder: clinical utility and psychometric properties of the treatment effectiveness assessment","volume":"10","author":"Ling","year":"2019","journal-title":"Subst. Abus. Rehabil."},{"key":"10.1016\/j.drugalcdep.2025.112993_bib20","first-page":"943","article-title":"A theory of human motivation","volume":"1","author":"Maslow","year":"1943","journal-title":"Psyhological Rev. Psychol. Rev."},{"issue":"1","key":"10.1016\/j.drugalcdep.2025.112993_bib21","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1016\/j.jsat.2004.10.010","article-title":"Predictors of alcohol and crack cocaine use outcomes over a 3-year follow-up in treatment seekers","volume":"28","author":"McKay","year":"2005","journal-title":"J. Subst. Abus. Treat."},{"issue":"13","key":"10.1016\/j.drugalcdep.2025.112993_bib22","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1001\/jama.284.13.1689","article-title":"Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation","volume":"284","author":"McLellan","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.drugalcdep.2025.112993_bib23","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.drugalcdep.2019.01.046","article-title":"Short and long-term improvements in psychiatric symptomatology to validate clinically meaningful treatment outcomes for cocaine use disorders","volume":"198","author":"Miguel","year":"2019","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2025.112993_bib24","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jsat.2019.09.002","article-title":"Change in employment status and cocaine use treatment outcomes: a secondary analysis across six clinical trials","volume":"106","author":"Miguel","year":"2019","journal-title":"J. Subst. Abus. Treat."},{"issue":"3","key":"10.1016\/j.drugalcdep.2025.112993_bib25","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1037\/pha0000482","article-title":"Validating the clinical relevance of alternative stimulant use treatment outcome measures by examining their association with 3-month follow-up outcomes","volume":"29","author":"Miguel","year":"2021","journal-title":"Exp. Clin. Psychopharm."},{"key":"10.1016\/j.drugalcdep.2025.112993_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108291","article-title":"Long-term functioning to provide empirical support for the clinical relevance of treatment outcomes for methamphetamine use disorders","volume":"124","author":"Miguel","year":"2021","journal-title":"J. Subst. Abus. Treat."},{"key":"10.1016\/j.drugalcdep.2025.112993_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108291","article-title":"Long-term functioning to provide empirical support for the clinical relevance of treatment outcomes for methamphetamine use disorders","volume":"124","author":"Miguel","year":"2021","journal-title":"J. Subst. Abus. Treat."},{"issue":"2","key":"10.1016\/j.drugalcdep.2025.112993_bib28","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.cct.2012.11.002","article-title":"Cocaine use reduction with buprenorphine (CURB): rationale, design, and methodology","volume":"34","author":"Mooney","year":"2013","journal-title":"Contemp. Clin. Trials"},{"key":"10.1016\/j.drugalcdep.2025.112993_bib29","series-title":"Mplus User's Guide","author":"Muthen","year":"1998-2023"},{"issue":"1","key":"10.1016\/j.drugalcdep.2025.112993_bib30","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13722-022-00316-3","article-title":"Cumulative barriers to retention in methadone treatment among adults from rural and small urban communities","volume":"17","author":"Pasman","year":"2022","journal-title":"Addict. Sci. Clin. Pract."},{"issue":"9","key":"10.1016\/j.drugalcdep.2025.112993_bib31","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S1470-2045(09)70200-1","article-title":"Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials","volume":"10","author":"Quinten","year":"2009","journal-title":"Lancet Oncol."},{"issue":"6","key":"10.1016\/j.drugalcdep.2025.112993_bib32","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1097\/EDE.0000000000001064","article-title":"Mediational E-values: approximate sensitivity analysis for unmeasured mediator\u2013outcome confounding","volume":"30","author":"Smith","year":"2019","journal-title":"Epidemiology"},{"key":"10.1016\/j.drugalcdep.2025.112993_bib33","article-title":"Targeting the barriers in the substance use disorder continuum of care with peer recovery support","volume":"15","author":"Stanojlovi\u0107","year":"2021","journal-title":"Subst. Abus. Res. Treat."},{"key":"10.1016\/j.drugalcdep.2025.112993_bib34","unstructured":"Substance Abuse and Mental Health Services Administration (SAMHSA), 2023. Racial\/Ethnic Differences in Substance Use, Substance Use Disorders, and Substance Use Treatment Utilization Among People Aged 12 or Older (2015-2019)."},{"issue":"4","key":"10.1016\/j.drugalcdep.2025.112993_bib35","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1360-0443.2011.03581.x","article-title":"Beyond drug use: a systematic consideration of other outcomes in evaluations of treatments for substance use disorders","volume":"107","author":"Tiffany","year":"2012","journal-title":"Addiction"},{"issue":"10","key":"10.1016\/j.drugalcdep.2025.112993_bib36","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1007\/s00127-007-0236-6","article-title":"Substance abuse and quality of life among severely mentally ill consumers: a longitudinal modelling analysis","volume":"42","author":"Urbanoski","year":"2007","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"key":"10.1016\/j.drugalcdep.2025.112993_bib37","series-title":"Explanation in causal inference: Methods for mediation and interaction","author":"VanderWeele","year":"2015"},{"key":"10.1016\/j.drugalcdep.2025.112993_bib38","article-title":"Psychometric properties of the treatment effectiveness assessment in methamphetamine use disorder","volume":"151","author":"Vo","year":"2023","journal-title":"J. Subst. Use Addict. Treat."},{"issue":"2","key":"10.1016\/j.drugalcdep.2025.112993_bib39","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/wps.21073","article-title":"Substance use disorders: a comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and prevention","volume":"22","author":"Volkow","year":"2023","journal-title":"World Psychiatry"},{"issue":"2","key":"10.1016\/j.drugalcdep.2025.112993_bib40","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1037\/a0023031","article-title":"Interaction effects of age and contingency management treatments in cocaine-dependent outpatients","volume":"19","author":"Weiss","year":"2011","journal-title":"Exp. Clin. Psychopharm."},{"issue":"2","key":"10.1016\/j.drugalcdep.2025.112993_bib41","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1521-0391.2013.00306.x","article-title":"Older methadone patients achieve greater durations of cocaine abstinence with contingency management than younger patients","volume":"22","author":"Weiss","year":"2013","journal-title":"Am. J. Addict."},{"issue":"1","key":"10.1016\/j.drugalcdep.2025.112993_bib42","first-page":"E9","article-title":"\"Success\" following alcohol treatment: moving beyond abstinence","volume":"37","author":"Witkiewitz","year":"2013","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.drugalcdep.2025.112993_bib43","unstructured":"World Health Organization, W.G., World Health Organization, W.G., Development of the WHOQOL-BREF quality of life Assessment. Psychol Med [Internet] 28(3). n.d."},{"issue":"1","key":"10.1016\/j.drugalcdep.2025.112993_bib44","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1080\/01612840.2016.1245375","article-title":"Recovery in substance use disorders: what to know to inform practice","volume":"38","author":"Worley","year":"2017","journal-title":"Issues Ment. Health Nurs."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871625004466?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871625004466?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T04:10:06Z","timestamp":1781323806000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871625004466"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":44,"alternative-id":["S0376871625004466"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2025.112993","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quality of life and treatment effectiveness direct and indirect effects on cocaine abstinence outcomes during cocaine use disorder treatment","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2025.112993","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"112993"}}